Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$812K Sell
16,425
-1,800
-10% -$86.5K 0.22% 108
2020
Q4
$886K Sell
18,225
-1,000
-5% -$49.3K 0.25% 94
2020
Q3
$965K Buy
19,225
+750
+4% +$38.6K 0.3% 76
2020
Q2
$943K Buy
18,475
+500
+3% +$24.3K 0.31% 75
2020
Q1
$786K Sell
17,975
-200
-1% -$9.57K 0.33% 78
2019
Q4
$912K Buy
18,175
+150
+0.8% +$7.03K 0.31% 87
2019
Q3
$835K Sell
18,025
-300
-2% -$12.9K 0.31% 89
2019
Q2
$793K Hold
18,325
0.3% 89
2019
Q1
$811K Sell
18,325
-275
-1% -$11.8K 0.3% 91
2018
Q4
$807K Sell
18,600
-3,875
-17% -$171K 0.33% 84
2018
Q3
$1M Sell
22,475
-1,875
-8% -$80.1K 0.36% 80
2018
Q2
$974K Sell
24,350
-2,977
-11% -$117K 0.37% 74
2018
Q1
$1.08M Sell
27,327
-3,573
-12% -$149K 0.44% 58
2017
Q4
$1.33M Sell
30,900
-2,730
-8% -$126K 0.55% 50
2017
Q3
$1.67M Sell
33,630
-3,585
-10% -$173K 0.73% 39
2017
Q2
$1.78M Sell
37,215
-1,575
-4% -$75.3K 0.79% 39
2017
Q1
$1.83M Sell
38,790
-9,075
-19% -$385K 0.81% 38
2016
Q4
$2.04M Sell
47,865
-1,365
-3% -$53.8K 0.9% 35
2016
Q3
$1.88M Buy
+49,230
New +$1.98M 1.49% 20

Other funds holding SNY

Rikoon Group's SNY Position: Q1 2021 in Review

Rikoon Group reduced its Sanofi (SNY) stake by 9.9% in Q1 2021, selling an estimated $86.5K and leaving 16,425 shares worth $812K. The position accounts for 0.22% of the portfolio, ranked #108.

Rikoon Group first reported a position in SNY in Q3 2016 and has held it in 19 quarters since. The position peaked at $2.04M in Q4 2016. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Rikoon Group held 16,425 shares of Sanofi worth $812K as of Q1 2021.
  • Rikoon Group sold 1,800 Sanofi shares in Q1 2021, an estimated $86.5K.
  • Sanofi made up 0.22% of Rikoon Group's portfolio in Q1 2021, its #108 holding.
  • Rikoon Group first reported a position in Sanofi in Q3 2016 and has held it in 19 quarters since.
  • Rikoon Group's Sanofi position peaked at $2.04M in Q4 2016.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.